Myomo (NYSE:MYO) announced today that it priced an underwritten offering of common stock worth proceeds of approximately $15 million. The Boston-based wearable exoskeleton maker is offering 3 million shares of common stock priced at $5 per share. In connection with the offering, the company granted the underwriter a 30-day option to purchase up to 450,000 […]
Myomo Inc
Myomo has a strong outlook for 2024 with new Medicare coverage
Myomo (NYSE:MYO) shares took a hit today on fourth-quarter results that came up short of the consensus forecast. Shares of MYO fell 10% to $3.16 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — ticked up 0.5%. The Boston-based wearable exoskeleton maker posted […]
Myomo to raise $6M with eyes on Medicare coverage
Myomo (NYSE:MYO) announced today that it entered into securities purchase agreements worth approximately $6 million. The company entered into agreements with certain new and existing institutional investors, plus insiders at Myomo. This agreement includes nearly 1.6 million shares of common stock priced at $3.80 per share. In conjunction with the offering, Myomo disclosed that it […]
Myomo prices $4.4M offering, scores reimbursement win
Myomo (NYSE:MYO) announced today that it priced a “reasonable best efforts” public offering worth proceeds of approximately $4.4 million. Boston-based Myomo’s offering includes more than 7.3 million shares of common stock priced at 60¢ per share. The company expects to close the offering on or about Aug. 29, 2023, subject to customary conditions. Myomo develops […]
Myomo rises on Street-beating Q4
Myomo (NYSE:MYO) shares ticked up this morning on fourth-quarter results that topped the consensus forecast. The Boston-based wearable medical robotics company posted losses of -$1.7 million, or -37¢ per share, on sales of $3.8 million for the three months ended Dec. 31, 2020, for a 38.5% bottom-line gain on revenues that were more than doubled […]
Myomo lands Medicare coverage
Myomo (NYSE:MYO) announced that it received authorization to be a Medicare provider through the Centers for Medicare & Medicaid Services. CMS, under the U.S. Dept. of Health and Human Services, now includes Cambridge, Mass.-based Myomo in its Medicare Supplier Directory at Medicare.gov, which enables Myomo to bill Medicare directly when it delivers its MyoPro orthosis in […]
Myomo launches MyoCare
Myomo (NYSE:MYO) announced today that it launched its MyoCare program for providing support to first-year users of its MyoPro powered brace. MyoCare offers expanded support to current and future clients who receive their MyoPro directly from the Cambridge, Mass.-based company, at no additional cost. Anyone who obtained the MyoPro from an authorized orthotics & prosthetics clinic […]
COVID-19 upends medtech’s financial outlook
The uncertain times brought on by the COVID-19 pandemic have affected businesses worldwide, and several sectors of medtech industry are projecting hits to their bottom lines. A number of companies have announced decisions to withdraw financial guidance, cut hours and/or staff, among other major business decisions. Initial impacts of the global pandemic on Wall Street […]
Myomo drops on Q4 losses
Myomo (NYSE:MYO) shares took a hit today on fourth-quarter results that missed the consensus forecast for earnings but topped the revenue projections. The Cambridge, Mass.-based commercial-stage medical robotics company yesterday evening posted losses of $2.8 million, or -$4.81 per share, on sales of $1.5 million for the three months ended Dec. 31, 2019, for a 2.6% […]
Myomo closes $15m public offering
Myomo (NYSE:MYO) announced that it closed its previously announced underwritten public offering of common stock or common stock equivalents for gross proceeds of $15 million. The offering included more than 2.1 million shares of Cambridge, Mass.–based Myomo’s common stock or equivalents, along with an equal amount of investor warrants to purchase one share of common stock […]
Myomo shares down on news of $15m public offering
Shares of Myomo (NYSE:MYO) took a dive in price today after the commercial-stage medical robotics company announced it would raise $15 million from a public offering. MYO shares were down nearly 45% to $6.46 apiece by the afternoon. The company — maker of the MyoPro upper limb orthosis — is selling more than 2.1 million shares […]
